ALFA Filings
Every announcement, straight from the exchange
Every Dr. Lal Pathlabs other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
8 announcements with these filters
Dr. Lal PathLabs submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, received from its RTA.
Dr. Lal PathLabs reported PIT disclosures for trades by designated persons and its Employee Welfare Trust, totaling approximately ₹0.83 Crore. These involved ESOP allotments and market sales.
Dr. Lal PathLabs discloses share transactions by designated persons and an employee welfare trust under PIT regulations.
Designated persons at Dr. Lal PathLabs Ltd disclosed three equity trades totaling Rs. 0.50 Crore, as mandated under Insider Trading regulations.
Designated persons and the employee welfare trust of Dr. Lal PathLabs Ltd disclosed share transactions under PIT Regulations. These trades involve ESOP-related activities and market sales.
Designated Person Abhishek Maini acquired 500 equity shares via ESOP and subsequently sold 500 shares. This is a routine regulatory disclosure of personal trading activity.
Dr. Lal PathLabs Ltd filed its quarterly shareholding pattern as of June 30, 2026. The filing details the distribution of equity shares across various investor categories.
Dr. Lal PathLabs has sent letters to shareholders without registered emails. The communication provides a web-link to access the Annual Report for FY 2025-26.